检索结果 - Frost, Adaani E
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
-
5
The echocardiographic course of pretransplant pulmonary hypertension following kidney transplantation and associated outcomes 由 Frost, Adaani E., Moore, Linda W., Valdivia e Alvarado, Miguel, Obi, Chizoba, Graviss, Edward A., Nguyen, Duc T., Gaber, Ahmed Osama, Suki, Wadi N.
出版 2022Text -
6
Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry 由 Frantz, Robert P., Farber, Harrison W., Badesch, David B., Elliott, C. Greg, Frost, Adaani E., McGoon, Michael D., Zhao, Carol, Mink, David R., Selej, Mona, Benza, Raymond L.
出版 2018Text -
7
Delay in Recognition of Pulmonary Arterial Hypertension: Factors Identified From the REVEAL Registry 由 Brown, Lynette M., Chen, Hubert, Halpern, Scott, Taichman, Darren, McGoon, Michael D., Farber, Harrison W., Frost, Adaani E., Liou, Theodore G., Turner, Michelle, Feldkircher, Kathy, Miller, Dave P., Elliott, C. Gregory
出版 2011Text -
8
Selective endothelin(A) receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease 由 Girgis, Reda E, Frost, Adaani E, Hill, Nicholas S, Horn, Evelyn M, Langleben, David, McLaughlin, Vallerie V, Oudiz, Ronald J, Robbins, Ivan M, Seibold, James R, Shapiro, Shelley, Tapson, Victor F, Barst, Robyn J
出版 2007Text -
9
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension 由 White, R. James, Vonk-Noordegraaf, Anton, Rosenkranz, Stephan, Oudiz, Ronald J., McLaughlin, Vallerie V., Hoeper, Marius M., Grünig, Ekkehard, Ghofrani, Hossein-Ardeschir, Chakinala, Murali M., Barberà, Joan A., Blair, Christiana, Langley, Jonathan, Frost, Adaani E.
出版 2019Text -
10
Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study 由 Frantz, Robert P., Schilz, Robert J., Chakinala, Murali M., Badesch, David B., Frost, Adaani E., McLaughlin, Vallerie V., Barst, Robyn J., Rosenberg, Daniel M., Miller, Dave P., Hartline, Brian K., Benton, Wade W., Farber, Harrison W.
出版 2015Text -
11
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications 由 Elliott, C. Gregory, Austin, Eric D., Badesch, David, Badlam, Jessica, Benza, Raymond L., Chung, Wendy K., Farber, Harrison W., Feldkircher, Kathy, Frost, Adaani E., Poms, Abby D., Lutz, Katie A., Pauciulo, Michael W., Yu, Chang, Nichols, William C.
出版 2019Text -
12
United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics 由 Badlam, Jessica B., Badesch, David B., Austin, Eric D., Benza, Raymond L., Chung, Wendy K., Farber, Harrison W., Feldkircher, Kathy, Frost, Adaani E., Poms, Abby D., Lutz, Katie A., Pauciulo, Michael W., Yu, Chang, Nichols, William C., Elliott, C. Gregory
出版 2021Text -
13
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION tr... 由 Coghlan, John Gerry, Galiè, Nazzareno, Barberà, Joan Albert, Frost, Adaani E, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M, Kuwana, Masataka, McLaughlin, Vallerie V, Peacock, Andrew J, Simonneau, Gérald, Vachiéry, Jean-Luc, Blair, Christiana, Gillies, Hunter, Miller, Karen L, Harris, Julia H N, Langley, Jonathan, Rubin, Lewis J
出版 2017Text